Written by the Nuvirox Research Team
Key points
- Curcumin and boswellia (frankincense) target inflammation through different pathways, and the best human trial testing them together found the combination beat curcumin alone.
- Both have real randomized trial support for joint pain, but the head-to-head evidence is thinner than the marketing suggests — most “comparisons” are actually combination studies.
- Neither replaces a diagnosis: persistent joint pain deserves a doctor's evaluation, especially if it's new, one-sided, or accompanied by swelling.
Short answer: they are not really competitors — the best evidence says they work better together than either does alone. Curcumin, the pigment in turmeric, and boswellic acids, the resin extract from Boswellia serrata (Indian frankincense), are both marketed as natural alternatives to NSAIDs for joint pain. People searching “curcumin vs boswellia” are usually trying to decide which one to buy. But the largest relevant randomized trial did not pit them against each other head to head — it tested curcumin alone, curcumin plus boswellic acid, and placebo, in people with osteoarthritis. The combination won.
How do curcumin and boswellia actually differ?
They interrupt inflammation at different points. Curcumin is best known for dampening NF-κB, a master switch that turns on inflammatory gene expression, and for inhibiting COX-2 and several inflammatory cytokines. Boswellic acids work more specifically on 5-lipoxygenase (5-LOX), an enzyme that produces leukotrienes — inflammatory signaling molecules that curcumin does not touch as directly. That non-overlapping mechanism is the theoretical reason researchers pair them, and it is also why a head-to-head “which one wins” framing may be the wrong question for most people with joint pain.
What does the human evidence actually show?
Haroyan et al. (2018), a 12-week randomized, double-blind, placebo-controlled trial (BMC Complementary Medicine and Therapies, PMID 29316908), enrolled 201 people aged 40–70 with osteoarthritis and split them into three arms: a curcumin complex (CuraMed®), a curcumin-plus-boswellic-acid combination (Curamin®), and placebo. Both active groups improved on physical function tests versus placebo, but only the combination group showed a significant improvement on the WOMAC joint pain index, and its effect size was larger than curcumin alone. The authors described this as consistent with a synergistic effect between the two compounds.
A separate pilot RCT of boswellia alone (Majeed et al., 2019, Phytotherapy Research, PMID 30838706) tested a novel Boswellia serrata extract against placebo in 48 people with knee osteoarthritis over 120 days and found improved physical function and reduced high-sensitivity C-reactive protein (hs-CRP), with no serious adverse events — evidence that boswellia has standalone activity, not just an additive role.
The honest counterweight: a systematic review and meta-analysis of curcuminoid and boswellia formulations for knee osteoarthritis (Scientific Reports/Semin Arthritis Rheum literature, summarized in the ScienceDirect meta-analysis on this topic) noted that despite the promising signal, there are still “very few randomized controlled trials” testing these formulations, sample sizes are modest, trial durations are short (weeks, not years), and few studies have directly compared the two head-to-head rather than testing a fixed combination. That is a real limitation: most of what looks like “curcumin vs boswellia” evidence is actually “curcumin plus boswellia vs curcumin alone,” which answers a different question than the one most shoppers are asking.
What won’t curcumin or boswellia do?
It is also worth setting expectations relative to weaker-evidence turmeric claims you may have seen elsewhere — for example, curcumin’s essentially untested case for hair loss — so that a research-grounded joint-pain decision does not get conflated with far thinner claims made about the same ingredient elsewhere. Neither curcumin nor boswellia has been shown to reverse existing joint damage or replace disease-modifying treatment for inflammatory arthritis. Effect sizes in these trials, while statistically real, are moderate — closer to a meaningful reduction in day-to-day discomfort than a cure. If pain is new, one-sided, associated with swelling, fever, or morning stiffness lasting over an hour, that pattern deserves a doctor’s evaluation rather than a supplement trial-and-error approach; those symptoms can point to inflammatory arthritis or another condition that benefits from earlier diagnosis.
Dosing in the trials
In the Haroyan trial, the combination arm used 500 mg capsules containing 350 mg curcuminoids plus 150 mg boswellic acid, taken three times daily (1,500 mg total per day) for 12 weeks — in line with curcuminoid doses used across most published curcumin research. The standalone boswellia pilot used a different extract and dosing schedule over 120 days. Neither trial ran long enough to say anything about multi-year use.
FAQ
Should I take curcumin and boswellia together or pick one?
The best available trial evidence favors the combination over curcumin alone for joint pain, but that is one 12-week trial in osteoarthritis — not a universal answer for every kind of joint or muscle pain.
Is boswellia safe to take with a turmeric supplement?
Both were well tolerated in the trials reviewed here with no serious adverse events reported, but neither trial screened specifically for interactions with blood thinners or other medications, so check with your doctor if you take prescription drugs.
Does curcumin or boswellia work faster?
Both trials measured effects at multiple weeks in, not days; neither ingredient is positioned as a fast-acting pain reliever the way an NSAID is.
Is this comparison specific to knee osteoarthritis?
Yes — nearly all the RCT evidence covered here is in osteoarthritis patients. Extrapolating to other joint or muscle pain sources, like tendonitis or autoimmune arthritis, goes beyond what these trials tested.
From Nuvirox
Why we formulated Turmeric with BioPerine
If you are exploring turmeric as part of your joint-support routine, Turmeric with BioPerine is formulated to pair curcumin with black pepper extract for absorption. We're not making comparative claims against boswellia here — just offering it as one well-studied option to discuss with your doctor.
Learn more about Turmeric with BioPerine →The bottom line
The fair reading of the evidence is not “curcumin vs boswellia” but “curcumin, possibly with boswellia, for osteoarthritis joint pain, based on modest but real trial support.” If you already manage joint discomfort with curcumin for joint pain, the Haroyan trial is a reasonable basis for asking your doctor about adding a boswellia extract rather than switching entirely.
How other researchers have tried to build on this finding
Since the Haroyan trial, several smaller studies have explored related angles. An open-label pre-post trial looked specifically at a curcumin-Boswellia serrata combination for hand osteoarthritis, a joint area with fewer treatment studies than the knee, and reported that the combination was more effective in participants with more severe baseline pain — though as an open-label design without a placebo arm, it carries less weight than the randomized Haroyan trial. A 2025 network meta-analysis pooling multiple curcumin and boswellia trials in knee osteoarthritis (published in a peer-reviewed journal and searched through CENTRAL, PubMed, EMBASE, and EBSCO databases) set out to more rigorously quantify the comparative and combined effects using standard outcome measures like the WOMAC index and adverse event rates — a sign the field recognizes this as an open, worthwhile question rather than settled science.
It is also worth noting what these ingredients have not been tested for. Neither curcumin nor boswellic acid, alone or combined, has strong trial evidence specifically for inflammatory or autoimmune forms of arthritis like rheumatoid arthritis, which involve a different disease process than osteoarthritis and typically require disease-modifying medication. If your joint pain comes with prolonged morning stiffness, symmetrical joint swelling, or a family history of autoimmune disease, that pattern points toward a rheumatology referral rather than a supplement decision.
Related reading in our turmeric library
If you are comparing joint-support approaches, these cover adjacent ground:
- how turmeric compares with ginger for general inflammation
- how different curcumin absorption technologies compare
References
- Haroyan A, Mukuchyan V, Mkrtchyan N, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018;18:7. PMID: 29316908.
- Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res. 2019;33(5):1457-1468. PMID: 30838706.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.